RNAC - Cartesian Therapeutics, Inc.
10.15
-0.420 -4.138%
Share volume: 74,078
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$10.57
-0.42
-0.04%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-04-2023 | 08-17-2023 | 11-13-2023 | 03-07-2024 | 05-08-2024 | 08-08-2024 | 11-07-2024 | 03-13-2025 | |
| Total revenue | 5.938 M | 5.249 M | 6.551 M | 8.266 M | 5.840 M | 33.445 M | 387.000 K | -759.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 5.938 M | 5.249 M | 6.551 M | 8.266 M | 5.840 M | 33.445 M | 387.000 K | -759.000 K | |
| -11.60% | 24.80% | 26.18% | -29.35% | 472.69% | -98.84% | -296.12% | |||
| Operating expenses | 24.319 M | 23.887 M | 19.616 M | 44.598 M | 19.188 M | 19.688 M | 17.962 M | 18.393 M | |
| Selling general and admin | 5.695 M | 6.105 M | 6.614 M | 22.167 M | 9.450 M | 7.027 M | 6.562 M | 7.087 M | |
| Research and development | 18.624 M | 17.782 M | 13.002 M | 22.431 M | 9.738 M | 12.661 M | 11.400 M | 11.306 M | |
| Total expenses | 24.319 M | 23.887 M | 19.616 M | 44.598 M | 19.188 M | 19.688 M | 17.962 M | 25.972 M | |
| -1.78% | -17.88% | 127.36% | -56.98% | 2.61% | -8.77% | 44.59% | |||
| Operating income | -18.381 M | -18.638 M | -13.065 M | -36.332 M | -13.348 M | 13.757 M | -17.575 M | -26.731 M | |
| Ebit | -18.381 M | -18.638 M | -13.065 M | -36.332 M | -13.348 M | 13.757 M | -27.006 M | -26.731 M | |
| Pretax income | -21.663 M | -11.387 M | -9.002 M | -196.658 M | -56.824 M | 14.952 M | -24.433 M | -10.324 M | |
| -47.44% | -20.94% | 2,084.60% | -71.11% | -126.31% | -263.41% | -57.75% | |||
| Income tax | 0.000 | 0.000 | 0.000 | -19.000 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -21.663 M | -11.387 M | -9.002 M | -177.658 M | -56.824 M | 0.000 | 0.000 | 0.000 | |
| 47.44% | 20.94% | -1,873.54% | 68.01% | 100.00% | |||||
| Net income | -21.663 M | -11.387 M | -9.002 M | -177.658 M | -56.824 M | 13.836 M | -24.183 M | -10.253 M | |
| 47.44% | 20.94% | -1,873.54% | 68.01% | 124.35% | -274.78% | 57.60% |
